Ligand validation:4Q09

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4Q09_EDO_A_304	69%	53%	0.123	0.937	1	0.82	-	-	0	0	100%	1
4Q09_EDO_A_307	60%	20%	0.175	0.96	1.02	2.34	-	1	1	0	100%	1
4Q09_EDO_A_306	45%	52%	0.169	0.901	1.45	0.44	-	-	0	0	100%	1
4Q09_EDO_A_308	28%	65%	0.253	0.907	0.97	0.38	-	-	1	0	100%	1
4Q09_EDO_A_305	21%	4%	0.192	0.8	4.54	1.23	3	-	0	0	100%	1
5OGO_EDO_A_307	51%	68%	0.194	0.95	0.87	0.37	-	-	1	0	100%	1
5LLC_EDO_A_306	35%	38%	0.245	0.937	1.04	1.4	-	-	1	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.